Apartments Proposed to Replace Denver Pharmaceutical Plant

Rendered perspective: NE corner, Alameda and cherokee view.

Austin-based Cypress Real Estate Advisors Inc. that provides real estate investment management and advisory services in the U.S., has proposed a 359-unit apartment project at 301 S.Cherokee St. in Denver. The site is currently occupied by an industrial plant owned by a pharmaceutical company that manufactures generic drugs.

The plant has non-historic status, according to city records, which makes demolition possible within the next five years.

The proposed apartments are adjacent to Broadway Park, a 75-acre transit-oriented development from master developer D4 Urban.

KTGY Architecture submitted a design review package to the city that details seven floors of residential units including a combination of studios and one- and two-bedroom units. Three levels of parking amounting to 374 parking spaces are also proposed as well as 1,444 square feet of retail. However, it is important to note that the package is yet to be reviewed by the city and could change significantly.

The overall site plan also outlines the possibility for a future phase of development on an adjacent lot.

Mile High CRE will continue to keep you updated on this proposed development as more information becomes available.

Renderings courtesy of City of Denver


Related Posts

Scroll to Top